Get the Stockscreener App
0.1895
22.91%
-0.0536
After Hours:
.19
0.0005
+0.26%
Ocean Biomedical Inc stock is traded at $0.1895, with a volume of 19.67M.
It is down -22.91% in the last 24 hours and down -68.77% over the past month.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.
See More
Previous Close:
$0.2431
Open:
$0.2351
24h Volume:
19.67M
Relative Volume:
5.91
Market Cap:
$7.14M
Revenue:
-
Net Income/Loss:
$-82.19M
P/E Ratio:
-0.0612
EPS:
-3.0969
Net Cash Flow:
$-8.35M
1W Performance:
-58.36%
1M Performance:
-68.77%
6M Performance:
-83.70%
1Y Performance:
-68.23%
1-Day Range:
$0.1821
$0.2566
1-Week Range:
$0.1821
$0.6594
52-Week Range:
$0.1821
$7.79
Ocean Biomedical Inc Stock (OCEA) Company Profile
Name
Ocean Biomedical Inc
Sector
Industry
Phone
(646) 908-2658
Address
515 MADISON AVE SUITE 8078, NEW YORK
Compare OCEA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OCEA
Ocean Biomedical Inc
|
0.1895 | 7.14M | 0 | -82.19M | -8.35M | -3.0969 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 113.67B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 74.97B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.50B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 29.63B | 3.30B | -501.07M | 1.03B | -2.1146 |
Ocean Biomedical Inc Stock (OCEA) Latest News
Ocean Biomedical stock plunges to 52-week low of $0.28 - MSN
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Ocean Biomedical stock plunges to 52-week low of $0.28 By Investing.com - Investing.com UK
Stock market news: Aclarion plunged by 99.74% while Signing Day Sports surged by 125.77% during mid day trading - Business Upturn
Stock market today: Aclarion declined by 99.74% while Ocean Biomedical surged by 27.94% in early trading - Business Upturn
Ocean Biomedical Receives Additional NIH Funding for Malaria Vaccine Research; Shares Up Pre-Bell - Marketscreener.com
Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway - GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
Ocean Biomedical stock plunges to 52-week low of $0.46 - MSN
Biotech Stocks Are Tumbling — But The Top 5 Are Standouts - Investor's Business Daily
Ocean Biomedical faces Nasdaq delisting over meeting rules By Investing.com - Investing.com South Africa
Ocean Biomedical faces Nasdaq delisting over meeting rules - Investing.com
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.25% - MSN
Cameron & Mittleman wants to cut ties with Ocean BiomedicalProvidence Business First - The Business Journals
Ocean Biomedical Inc Com (OCEA) reports earnings - Quartz
Pre-market Movers: AVGR, TIVC, ATNF, SLGL... - RTTNews
Pre-market Movers: HSDT, PBM, MTEM, APTO... - RTTNews
Zero revenue, multiple lawsuits: Brown spinoff Ocean Biomedical caught in maelstrom - The Business Journals
Ocean Biomedical (NASDAQ:OCEA) Stock Quotes, Forecast and News Summary - Benzinga
Ocean Biomedical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 - Marketscreener.com
Ocean Biomedical stock hits 52-week low at $0.51 - Investing.com
Ocean Biomedical stock hits 52-week low at $0.51 By Investing.com - Investing.com UK
Ocean Biomedical appoints new auditing firm - Investing.com
Ocean Biomedical appoints new auditing firm By Investing.com - Investing.com UK
Ocean Biomedical faces Nasdaq delisting over market value - Investing.com
Ocean Biomedical faces Nasdaq delisting over share price - Investing.com
Ocean Biomedical faces Nasdaq delisting over share price By Investing.com - Investing.com Canada
Ocean Biomedical dismisses Deloitte as certifying accountant - Investing.com
Ocean Biomedical dismisses Deloitte as certifying accountant By Investing.com - Investing.com Nigeria
Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Down 16.6% in November - Defense World
Rubber Duck Research at Virginia Tech - Virginia Living
Bolt Biotherapeutics (BOLT) Stock Surges Amid Biotech Sector Mov - GuruFocus.com
Ocean Biomedical faces Nasdaq delisting - Providence Business News
Ocean Biomedical, Inc. Announces Receipt of Notice from - GlobeNewswire
Compugen (CGEN) Stock Dips Amidst Biotech Sector Movements - GuruFocus.com
Ocean Biomedical Faces Nasdaq Delisting Threat - TipRanks
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q - The Manila Times
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q - GlobeNewswire Inc.
Capricor Therapeutics (CAPR) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com
CO2 Energy Transition Corp. Announces Closing of Previously Announced IPO and Full Exercise of Over-allotment - EIN News
BW LPG takes delivery of vessel BW Capella - MSN
Class Action Lawsuit Against Bumble Inc. (NASDAQ:BMBL) - MSN
BeyondSpring (BYSI) Stock Drops Amid Biotech Sector Volatility - GuruFocus.com
Ocean Biomedical Inc Stock (OCEA) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.46%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):